Underpowered outpatient Chinese randomized trial of ivermectin (n=202) shows symptom resolution benefit: 74% vs…

Underpowered outpatient Chinese randomized trial of ivermectin (n=202) shows symptom resolution benefit: 74% vs 59% by day 21, Fisher p=.037.

As the p-stat goes against the authors’ negative narrative, IT IS OMITTED.

Nothing will surprise me anymore…
https://t.co/rQ2iRkK9vH https://t.co/mGsDzIhfhy